ANI Pharmaceuticals, Inc. (ANIP) 宣布其2025年第四季度及全年的财务业绩达到历史新高,展现出强劲的增长势头。同时,公司管理层对2026年的财务前景保持信心,并重申了既定的业绩目标。
ANI Pharmaceuticals, Inc. (ANIP) 宣布其2025年第四季度及全年的财务业绩达到历史新高,展现出强劲的增长势头。同时,公司管理层对2026年的财务前景保持信心,并重申了既定的业绩目标。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.